Welcome to DxGen, a pioneering South Korean bio-venture dedicated to revolutionizing in vitro diagnostic products. Our mission includes manufacturing, developing, and marketing cutting-edge diagnostic solutions, aiming to make healthcare accessible to all.
We bridge the gap between medical professionals and individuals by offering reliable, high-quality diagnostic tools. Our goal is to empower informed healthcare decisions.
As industry leaders, our focus is on crafting innovative IVD products empowering individuals to manage their health. Our experienced team ensures accurate results and user-friendliness. Committed to technological advancements, we focus on research and development, staying at the forefront in providing cutting-edge solutions.
Together, let's shape a world where anyone can understand their disease and take charge of their well-being with comprehensive and reliable diagnostic products from DxGen.
DxGen is a global leader in Point-Of-Care (POC) diagnostics, committed to empowering informed clinical decisions at the patient's side through cutting-edge technology. Our unwavering dedication to high-quality products and continuous innovation is reshaping healthcare standards. Join us in revolutionizing POC diagnostics and improving global patient outcomes. DxGen: Shaping the future of healthcare.
DxGen devoted to developing multi-marker for people with diabetes and tuberculosis. We provide total solution and offers tools and services to help developing POC products from concept through commercialization. Healthcare professionals will have reliable test results in minutes with the lab quality precision and accuracy while operating cost effectively.
Founders and leadership of the company are an experienced team composed of industry leaders with successful track records. A powerful combined team with strong R&D capabilities and experience is what truly drives innovation. We are building a global investor, strategic partner and customer base and plan to manufacture components in multiple locations worldwide.
Board of Directors
Dr. Jinwoo Lee is famous entrepreneur and has set out to pioneer In-Vitro Diagnostics (IVD) fields approach to global market by inventing Blood Glucose Monitoring System (BGMS), HbA1c, Hemoglobin meter and Point-of-care (POC) diagnostics systems.
Prof. Tae Jung Park received his Ph.D. degree at the Department of Chemical & Biomolecular Engineering of KAIST in 2004. He has been a professor at the Chemistry department of Chung-Ang University.
Hyukjun Oh received the B.S., M.S., and Ph.D. degrees from the Korea Advanced Institute of Science and Technology (KAIST), in 1993, 1995, and 1999, respectively.
Prof.Sung Tack Chung received his Ph.D. degree at the Department of Electronic Engineering of KAIST. He has been a professor at the Computer Science department of Korea Poly-technic University from 2004.